The Imperative Trial: Treatment of Acute Ischemic Stroke With the Zoom Reperfusion System
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Emir Deljkich
Imperative Care, Inc.
Study Director - Raul G Nogueira, MD
University of Pittsburgh
Principal Investigator - Reade A De Leacy, MD
Icahn School of Medicine at Mount Sinai
Principal Investigator - William J Mack, MD
University of Southern California
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
28 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Radiology of Huntsville
Huntsville, Alabama, United States
- Carondelet Neurological Institute St. Joseph'S Hospital
Tucson, Arizona, United States
- University of Southern California
Los Angeles, California, United States
- John Muir Health
Walnut Creek, California, United States
- Baptist Health
Jacksonville, Florida, United States
- University of Miami / Jackson Memorial Hospital
Miami, Florida, United States
- Tallahassee Neurological Clinic
Tallahassee, Florida, United States
- Tampa General Hospital / University of South Florida
Tampa, Florida, United States
- Grady Memorial Hospital / Emory University
Atlanta, Georgia, United States
- Ochsner Health
New Orleans, Louisiana, United States
- Spectrum Health
Grand Rapids, Michigan, United States
- Munson Medical Center
Traverse City, Michigan, United States
- Cooper University Health Care
Camden, New Jersey, United States
- the State University of New York at Buffalo
Buffalo, New York, United States
- Mount Sinai
New York, New York, United States
- Montefiore Medical Center
The Bronx, New York, United States
- the Ohio State University Medical Center
Columbus, Ohio, United States
- Oklahoma University
Oklahoma City, Oklahoma, United States
- Lehigh Valley Hospital
Allentown, Pennsylvania, United States
- Upmc
Pittsburgh, Pennsylvania, United States
- University of Pennsylvania
Pittsburgh, Pennsylvania, United States
- Prisma Health - Upstate
Greenville, South Carolina, United States
- Erlanger Health System: Tennessee Interventional and Imaging Associates
Chattanooga, Tennessee, United States
- Semmes Murphey Foundation / Methodist University Hospital
Memphis, Tennessee, United States
- Baylor Scott and White Research Institute
Dallas, Texas, United States
- Valley Baptist Medical Center
Harlingen, Texas, United States
- the University of Texas Health Science Center at Houston // Memorial Hermann Health System
Houston, Texas, United States
- University of Texas Health Science Center at San Antonio
San Antonio, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Oct 2021
- Primary completion
- 28 May 2024
- Completion
- 28 May 2024
- Last update posted
- 8 Aug 2025
- Registered enrollment
- 328
- Registry id
- NCT04129125
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 4 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.